ºÚÁÏÉçÇø leads Texas in dementia research, care and prevention
The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at ºÚÁÏÉçÇø, in partnership with UT Rio Grande Valley, is home to the South Texas Alzheimer’s Disease Research Center, Texas’ only National Institute on Aging (NIA)-designated Alzheimer’s Disease Research Center—one of just 35 nationwide.
The Biggs Institute for Alzheimer’s and Neurodegenerative Diseases is the region’s first comprehensive center dedicated to improving discovery of the basic abnormalities in Alzheimer’s disease and then developing new therapeutic strategies for treatment of all dementias through patient care, innovative research and clinical trials. Currently, there are nearly 7 million Americans living with Alzheimer’s. This number is expected to almost double in the next 26 years. Texas ranks fourth in the number of Alzheimer’s cases and second in the number of deaths.
ºÚÁÏÉçÇø of Texas Health Science Center at San Antonio will open a $100 million Center for Brain Health in 2025. The center is expected to enhance the institution’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and the Department of Neurology within the Joe R. and Teresa Lozano Long School of Medicine. The new center will feature an imaging suite equipped with a 7-Telsa magnet scanner and dedicated clinical spaces for treatment and rehabilitation.
The Biggs Institute works with academic, nonprofit and community partners across Texas to provide access to research opportunities, diagnosis and care.
Only NIA-designated Alzheimer’s Disease Research Center in Texas
Physicians, scientists and supportive staff working together to provide you comprehensive care
Center for Brain Health (opening in 2025), will be a comprehensive hub for brain research, collaboration and discoveries
In The News
An ancient movement technique is merging with cutting-edge technology in a novel study at ºÚÁÏÉçÇø of Texas Health Science Center at San Antonio (ºÚÁÏÉçÇø) aimed at preventing falls in people with Alzheimer’s disease and related dementias. Wei Liu, PhD, research director of the Human Performance and Rehabilitation Research Lab and associate […]
Five years after the height of the SARS-CoV-2 (COVID-19) pandemic, scientists are beginning to unveil the infection’s potential long-term effects on the brain. We now know that following an acute COVID-19 infection, between 10% and 35% of people suffer from lingering effects called long COVID. For some people, these effects can be mild and short-lived, […]
Hispanics face nearly double the risk of developing Alzheimer’s disease compared to non-Hispanic whites, according to the National Institutes of Health National Institute on Aging.